Endocrinology

Back to articles

Thyroid hormone suppression therapy improves survival in differentiated thyroid carcinoma

KEY POINT

In a recently published study, thyroid hormone suppression therapy (THST) improved overall survival (OS) in stage II to IV differentiated thyroid carcinoma patients.

SOURCES

Jonklaas J et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2006;16:1229–42.

Biondi B et al. Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab. 2005;1:32–40.